Cargando…
DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma
The epigenetic dysregulation of tumor suppressor genes is an important driver of human carcinogenesis. We have combined genome-wide DNA methylation analyses and gene expression profiling after pharmacological DNA demethylation with functional screening to identify novel tumor suppressors in diffuse...
Autores principales: | Schmid, Corina A., Robinson, Mark D., Scheifinger, Nicole A., Müller, Sebastian, Cogliatti, Sergio, Tzankov, Alexandar, Müller, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419353/ https://www.ncbi.nlm.nih.gov/pubmed/25847947 http://dx.doi.org/10.1084/jem.20141957 |
Ejemplares similares
-
Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007) -
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
por: Lee, S, et al.
Publicado: (2010) -
SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy
por: Gerlach, Magdalena M., et al.
Publicado: (2020) -
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018) -
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma
por: Stirm, Kristin, et al.
Publicado: (2021)